ATE285177T1 - Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen - Google Patents

Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen

Info

Publication number
ATE285177T1
ATE285177T1 AT96906519T AT96906519T ATE285177T1 AT E285177 T1 ATE285177 T1 AT E285177T1 AT 96906519 T AT96906519 T AT 96906519T AT 96906519 T AT96906519 T AT 96906519T AT E285177 T1 ATE285177 T1 AT E285177T1
Authority
AT
Austria
Prior art keywords
growth
cells
progenicial
hometopoietic
thiole
Prior art date
Application number
AT96906519T
Other languages
English (en)
Inventor
Robert L Capizzi
Alan F List
Original Assignee
Medimmune Oncology Inc
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Oncology Inc, Univ Arizona filed Critical Medimmune Oncology Inc
Application granted granted Critical
Publication of ATE285177T1 publication Critical patent/ATE285177T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96906519T 1995-02-17 1996-02-16 Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen ATE285177T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/390,713 US5846958A (en) 1995-02-17 1995-02-17 Methods of using aminothiols to promote hematopoietic progenitor cell growth
PCT/US1996/002188 WO1996025045A1 (en) 1995-02-17 1996-02-16 Thiols to promote hematopoietic progenitor cell growth

Publications (1)

Publication Number Publication Date
ATE285177T1 true ATE285177T1 (de) 2005-01-15

Family

ID=23543611

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96906519T ATE285177T1 (de) 1995-02-17 1996-02-16 Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen

Country Status (10)

Country Link
US (2) US5846958A (de)
EP (1) EP0809437B1 (de)
JP (1) JP4057648B2 (de)
AT (1) ATE285177T1 (de)
AU (1) AU694847B2 (de)
CA (1) CA2213322C (de)
DE (1) DE69634074T2 (de)
ES (1) ES2235183T3 (de)
PT (1) PT809437E (de)
WO (1) WO1996025045A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573253B2 (en) 1997-02-12 2003-06-03 Medimmune Oncology Inc. Methods for the administration of amifostine and related compounds
US6051563A (en) * 1997-02-12 2000-04-18 U.S. Bioscience, Inc. Methods for the administration of amifostine and related compounds
US5994409A (en) * 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6953777B2 (en) * 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
US6489312B1 (en) * 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
JP5242877B2 (ja) 2000-04-26 2013-07-24 オレゴン ヘルス アンド サイエンス ユニバーシティー チオールをベースとする化学保護剤の投与
US7053072B2 (en) 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
WO2003049693A2 (en) * 2001-12-06 2003-06-19 Wyeth Method and composition for inducing weight loss
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
AU2003296413A1 (en) * 2002-09-16 2004-04-30 Wyeth Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
WO2004039336A2 (en) * 2002-10-31 2004-05-13 Oregon Health & Science University Use of thiol-based compositions in treating chemotherapeutic agent-induced thrombocytopenia
US20070148154A1 (en) * 2004-12-17 2007-06-28 Universite Rene Descartes (Paris V) Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs
WO2007096901A1 (en) * 2006-02-24 2007-08-30 Natco Pharma Limited Novel dihydrate form of amifostine and process for its preparation
US20130230580A1 (en) * 2010-09-14 2013-09-05 Paul S. Frenette Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration
JP6892132B2 (ja) 2015-11-17 2021-06-18 ザ バーリントン エイチシー リサーチ グループ インコーポレイテッド アミノチオール及びその類似体の改善された保護及び送達のための方法
GB201706544D0 (en) * 2017-04-25 2017-06-07 Plasticell Ltd Method
RU2020108470A (ru) 2017-07-28 2021-08-30 Ниссан Кемикал Корпорейшн Аддитивная композиция для культуральной среды, аддитивное соединение для культуральной среды и способ культивирования клеток или тканей с использованием этой композиции и соединения
GB201817385D0 (en) 2018-10-25 2018-12-12 Plasticell Ltd Therapy
US20220144775A1 (en) 2019-01-30 2022-05-12 Nissan Chemical Corporation Hydrazide compound and kinase inhibitor
GB202303026D0 (en) 2023-03-01 2023-04-12 Plasticell Ltd Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892824A (en) * 1968-12-16 1975-07-01 Southern Res Inst S-{107 -({107 -aminoalkylamino)alkyl dihydrogen phosphorothioates
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
EP0394542A1 (de) * 1989-04-25 1990-10-31 American Cyanamid Company Wiederherstellung der Knochenmarkszellen mit synthetischen CSF-Induktoren
WO1991005571A1 (en) * 1989-10-10 1991-05-02 University Of Rochester Method for producing bone marrow growth cell factors
MX9205549A (es) * 1991-09-30 1993-05-01 Jess G Thoene Metodo para el tratamiento de vih.
US5824664A (en) * 1993-03-26 1998-10-20 U.S. Bioscience, Inc. Suppression of HIV expression by organic thiophosphate

Also Published As

Publication number Publication date
PT809437E (pt) 2005-05-31
DE69634074T2 (de) 2006-01-19
EP0809437A1 (de) 1997-12-03
ES2235183T3 (es) 2005-07-01
AU4986996A (en) 1996-09-04
US5906984A (en) 1999-05-25
DE69634074D1 (de) 2005-01-27
WO1996025045A1 (en) 1996-08-22
CA2213322C (en) 2008-05-13
CA2213322A1 (en) 1996-08-22
EP0809437A4 (de) 2001-05-09
EP0809437B1 (de) 2004-12-22
JPH11504000A (ja) 1999-04-06
AU694847B2 (en) 1998-07-30
US5846958A (en) 1998-12-08
MX9706255A (es) 1998-08-30
JP4057648B2 (ja) 2008-03-05

Similar Documents

Publication Publication Date Title
ATE285177T1 (de) Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen
ES2114786A1 (es) Tromboyetina. trombopoyetina recombinante y procedimiento de obtencion.
HUT75776A (en) Pyrazolo and pyrrolopyridines, their using, pharmaceutical compositions containing them and intermediates
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
DE69106586D1 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
ATE286139T1 (de) Replikationskompetente anti-tumor vektoren
DE69718469D1 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
DE3778089D1 (de) Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
DE69333351T2 (de) Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen
DE69531554D1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
IS1986B (is) Notkun CD137 til að stuðla að fjölgun jaðar-einkjörnunga
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
ATE96150T1 (de) Thioester und dessen verwendung zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischaemie und von reperfusionsyndromen.
ATE262343T1 (de) Verwendung von gnrh analogen zur behandlung von schizophrenie
JPS56154456A (en) S-alkyl-3-alkylthiopropionothioates, nanufacture and medicine
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0809437

Country of ref document: EP

REN Ceased due to non-payment of the annual fee